Sort
39,280 grants matching “leukemia”
Proteomic Study of Megakaryocyte Transcriptional Control
$353,930Alan B. Cantor · Boston Children'S Hospital · R01 · FY2007 · HL
Targeting cell trafficking as a new therapeutic modality for Multiple Myeloma
$353,927Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2009 · CA
CLL clonal evolution and the development of therapy-driven resistance
$353,902Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2019 · CA
Targeting CK2 oncogenic pathway to overcome drug resistance in high-risk leukemia
$353,876Sinisa Dovat · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2021 · CA
Targeting CK2 oncogenic pathway to overcome drug resistance in high-risk leukemia
$353,876Sinisa Dovat · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2018 · CA
Targeting CK2 oncogenic pathway to overcome drug resistance in high-risk leukemia
$353,876Sinisa Dovat · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2020 · CA
Targeting CK2 oncogenic pathway to overcome drug resistance in high-risk leukemia
$353,876Sinisa Dovat · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2017 · CA
Molecular understanding of cytokine-Ras signals in leukemic bone marrow
$353,777Jeroen Roose · University Of California, San Francisco · R01 · FY2015 · CA
Molecular understanding of cytokine-Ras signals in leukemic bone marrow
$353,777Jeroen Roose · University Of California, San Francisco · R01 · FY2017 · CA
Molecular understanding of cytokine-Ras signals in leukemic bone marrow
$353,777Jeroen Roose · University Of California, San Francisco · R01 · FY2018 · CA
Molecular understanding of cytokine-Ras signals in leukemic bone marrow
$353,777Jeroen Roose · University Of California, San Francisco · R01 · FY2016 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$353,748Tufts Medical Center · U10 · FY2000 · CA
Studies on ZAP, a broad-spectrum alphavirus inhibitor
$353,697Margaret R Macdonald · Rockefeller University · R01 · FY2008 · AI
Studies on ZAP, a broad-spectrum alphavirus inhibitor
$353,697Margaret R Macdonald · Rockefeller University · R01 · FY2009 · AI
Expression profiling of renal cell carcinoma utilizing tissue from CALGB 90206
$353,636Hyung L Kim · Cedars-Sinai Medical Center · R01 · FY2013 · CA
Elucidation of Human Natural Killer Cell Development
$353,610Aharon G Freud · Ohio State University · R01 · FY2017 · CA
Cytokine Regulation of Photoreceptor Gene Expression
$353,540John D. Ash · University Of Florida · R01 · FY2015 · EY
HIV-1 AND HIV-2 INFECTION OF NON-DIVIDING CELLS
$353,531University Of Pennsylvania · R01 · FY2002 · AI
The roles of pleckstrin-2 as a functional node in erythropoiesis
$353,530Peng Ji · Northwestern University At Chicago · R01 · FY2017 · DK
Clinical Trial Office
$353,508John C Byrd · Ohio State University · P30 · FY2009 · CA
Combination fusion toxin and cytarabine therapy of AML
$353,500Wake Forest University Health Sciences · R21 · FY2002 · CA
Discovery of Death Ligands Against Cancers
$353,500Kit S Lam · University Of California At Davis · R33 · FY2012 · CA
Epigenetic Targeting of Afro-Caribbean Variant of HTLV-1 Related Adult T-cell Leukemia-lymphoma
$353,492Juan Carlos Ramos · University Of Miami School Of Medicine · R01 · FY2020 · CA
Synthetic rescue of antigen-driven T cells and alloimmunity
$353,491Yi Zhang · Temple Univ Of The Commonwealth · R56 · FY2019 · AI
c-Abl and PKC-eta in Cell Development and Leukemia
$353,462Mark S. Schlissel · University Of California Berkeley · R01 · FY2008 · AI